co.don AG Share Price Börse Stuttgart

Equities

CNW

DE000A3E5C08

Pharmaceuticals

Delayed Börse Stuttgart 13:15:06 12/06/2024 BST 5-day change 1st Jan Change
0.0145 EUR -3.33% Intraday chart for co.don AG +11.11% +36.36%
Current month+3.45%
1 month-18.92%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2020 6.23M 6.71M 526M Sales 2021 9.8M 10.56M 827M Capitalization 33.89M 36.49M 2.86B
Net income 2020 -13M -14M -1.1B Net income 2021 -9M -9.69M -759M EV / Sales 2020 6.74 x
Net cash position 2020 3.15M 3.39M 266M Net cash position 2021 293K 315K 24.72M EV / Sales 2021 3.43 x
P/E ratio 2020
-2.91 x
P/E ratio 2021
-3.8 x
Employees -
Yield 2020 *
-
Yield 2021
-
Free-Float 38.31%
More Fundamentals * Assessed data
Dynamic Chart
1 week+11.11%
Current month+3.45%
1 month-18.92%
3 months+20.97%
6 months+33.93%
Current year+36.36%
More quotes
1 week
0.01
Extreme 0.009
0.02
1 month
0.01
Extreme 0.009
0.03
3 years
0.01
Extreme 0.008
3.02
5 years
0.01
Extreme 0.008
7.84
10 years
0.01
Extreme 0.008
23.79
More quotes
Managers TitleAgeSince
Investor Relations Contact - -
Members of the board TitleAgeSince
Chairman - 28/11/05
Director/Board Member - 06/07/10
More insiders
Date Price Change
12/06/24 0.0145 -3.33%
11/06/24 0.015 +42.86%
10/06/24 0.0105 -27.59%
07/06/24 0.0145 0.00%
06/06/24 0.0145 0.00%

Delayed Quote Börse Stuttgart, June 12, 2024 at 01:15 pm

More quotes
Co.don AG is a Germany-based company that is active in the tissue engineering and regenerative medicine industry. The Company manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal particular cartilage defects, lumbar disc herniation, non-union fractures and dental disorders. Those include co don chondrotransplant, which is used for cartilage treatment, particularly in the knee area; co don chondrosphere, which is a three-dimensional articular cartilage cultivated outside of the body; co don chondrotransplant DISC, for the regeneration of intervertebral discs, and co don osteotransplant DENT, which is an autologous bone cell transplant for dental applications. The Company is active domestically and in other European countries.
More about the company

Annual profits - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW